These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18347083)

  • 1. Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies.
    Jossé R; Aninat C; Glaise D; Dumont J; Fessard V; Morel F; Poul JM; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2008 Jun; 36(6):1111-8. PubMed ID: 18347083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells.
    Aninat C; Piton A; Glaise D; Le Charpentier T; Langouët S; Morel F; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2006 Jan; 34(1):75-83. PubMed ID: 16204462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
    Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
    Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coplanar and coplanar polychlorinated biphenyls potentiate genotoxicity of aflatoxin B1 in a human hepatocyte line by enhancing CYP1A2 and CYP3A4 expression.
    Chen Y; Liu Y
    Environ Pollut; 2019 Mar; 246():945-954. PubMed ID: 31159144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Drug Metabolism and Its Related Hepatotoxic Effects in HepaRG, Cryopreserved Human Hepatocytes, and HepG2 Cell Cultures.
    Yokoyama Y; Sasaki Y; Terasaki N; Kawataki T; Takekawa K; Iwase Y; Shimizu T; Sanoh S; Ohta S
    Biol Pharm Bull; 2018 May; 41(5):722-732. PubMed ID: 29445054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dinuclear copper(II) complexes with 6-(benzylamino)purine derivatives on AhR and PXR dependent expression of cytochromes P450 CYP1A2 and CYP3A4 genes in primary cultures of human hepatocytes.
    Dvorák Z; Vrzal R; Starha P; Klanicová A; Trávnícek Z
    Toxicol In Vitro; 2010 Mar; 24(2):425-9. PubMed ID: 19854261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of organic anion-transporting polypeptide 1B1 and CYP3A4 activities in primary human hepatocytes and HepaRG cells cultured in a dynamic three-dimensional bioreactor system.
    Ulvestad M; Darnell M; Molden E; Ellis E; Åsberg A; Andersson TB
    J Pharmacol Exp Ther; 2012 Oct; 343(1):145-56. PubMed ID: 22789711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity.
    Chang SY; Voellinger JL; Van Ness KP; Chapron B; Shaffer RM; Neumann T; White CC; Kavanagh TJ; Kelly EJ; Eaton DL
    Toxicol In Vitro; 2017 Apr; 40():170-183. PubMed ID: 28089783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.
    Liu Y; Flynn TJ; Xia M; Wiesenfeld PL; Ferguson MS
    Cell Biol Toxicol; 2015 Oct; 31(4-5):221-30. PubMed ID: 26377104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies.
    Probert PM; Chung GW; Cockell SJ; Agius L; Mosesso P; White SA; Oakley F; Brown CD; Wright MC
    Toxicol Sci; 2014 Feb; 137(2):350-70. PubMed ID: 24235770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of the HepaRG cell line model for drug toxicity studies using two different cultivation conditions: advantages and limitations.
    Hammour MM; Othman A; Aspera-Werz R; Braun B; Weis-Klemm M; Wagner S; Nadalin S; Histing T; Ruoß M; Nüssler AK
    Arch Toxicol; 2022 Sep; 96(9):2511-2521. PubMed ID: 35748891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aflatoxin B1 on nuclear receptors PXR, CAR, and AhR and their target cytochromes P450 mRNA expression in primary cultures of human hepatocytes.
    Ayed-Boussema I; Pascussi JM; Maurel P; Bacha H; Hassen W
    Int J Toxicol; 2012; 31(1):86-93. PubMed ID: 21994236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepines medazepam and midazolam are activators of pregnane X receptor and weak inducers of CYP3A4: investigation in primary cultures of human hepatocytes and hepatocarcinoma cell lines.
    Vrzal R; Kubesova K; Pavek P; Dvorak Z
    Toxicol Lett; 2010 Mar; 193(2):183-8. PubMed ID: 20080160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 1A1/2, 2B6 and 3A4 HepaRG Cell-Based Biosensors to Monitor Hepatocyte Differentiation, Drug Metabolism and Toxicity.
    Vlach M; Quesnot N; Dubois-Pot-Schneider H; Ribault C; Verres Y; Petitjean K; Rauch C; Morel F; Robin MA; Corlu A; Loyer P
    Sensors (Basel); 2019 May; 19(10):. PubMed ID: 31096615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies.
    Mueller D; Krämer L; Hoffmann E; Klein S; Noor F
    Toxicol In Vitro; 2014 Feb; 28(1):104-12. PubMed ID: 23850736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.